Filing Details

Accession Number:
0001209191-22-036001
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-10 17:05:45
Reporting Period:
2022-05-02
Accepted Time:
2022-06-10 17:05:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1087294 Cumberland Pharmaceuticals Inc CPIX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1490829 James Jones 2525 West End Avenue
Suite 950
Nashville TN 37203
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-02 30 $2.45 20,713 No 4 P Direct
Common Stock Acquisiton 2022-05-03 30 $2.42 20,743 No 4 P Direct
Common Stock Acquisiton 2022-05-04 30 $2.37 20,773 No 4 P Direct
Common Stock Acquisiton 2022-05-05 30 $2.35 20,803 No 4 P Direct
Common Stock Acquisiton 2022-05-06 30 $2.36 20,833 No 4 P Direct
Common Stock Acquisiton 2022-05-09 34 $2.63 20,867 No 4 P Direct
Common Stock Acquisiton 2022-05-10 34 $2.55 20,901 No 4 P Direct
Common Stock Acquisiton 2022-05-11 34 $2.37 20,935 No 4 P Direct
Common Stock Acquisiton 2022-05-12 34 $2.23 20,969 No 4 P Direct
Common Stock Acquisiton 2022-05-13 34 $2.32 21,003 No 4 P Direct
Common Stock Acquisiton 2022-05-16 34 $2.31 21,037 No 4 P Direct
Common Stock Acquisiton 2022-05-17 34 $2.35 21,071 No 4 P Direct
Common Stock Acquisiton 2022-05-18 34 $2.31 21,105 No 4 P Direct
Common Stock Acquisiton 2022-05-19 34 $2.29 21,139 No 4 P Direct
Common Stock Acquisiton 2022-05-20 34 $2.23 21,173 No 4 P Direct
Common Stock Acquisiton 2022-05-23 38 $2.17 21,211 No 4 P Direct
Common Stock Acquisiton 2022-05-24 38 $2.17 21,249 No 4 P Direct
Common Stock Acquisiton 2022-05-25 38 $2.15 21,287 No 4 P Direct
Common Stock Acquisiton 2022-05-26 38 $2.12 21,325 No 4 P Direct
Common Stock Acquisiton 2022-05-27 38 $2.13 21,363 No 4 P Direct
Common Stock Acquisiton 2022-05-31 38 $2.13 21,401 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.